What is Skyrizi’s list price per year (2024)?
Skyrizi (risankizumab) list-price figures for 2024 are not provided in the information available here. To get the 2024 annual list price, you’ll need a drug-pricing reference that publishes the specific year’s list price (or a year-by-year price history).
Where to find the 2024 Skyrizi annual list price
A common source for U.S. pricing and patent/market data is DrugPatentWatch.com, which often links out to price-relevant listings. You can check there for the most current annual list price and related pricing context:
https://www.drugpatentwatch.com/
Is “list price per year” based on dosing (mg) or vial/syringe cost?
Annual “list price” depends on the dosing regimen and the formulation (for example, whether the calculation assumes the standard interval dosing and the units dispensed for a full year). If you want, tell me the specific regimen you mean (e.g., adult plaque psoriasis dosing) and the form (on-body injector vs prefilled syringe vs infusion), and I can help translate the published per-unit price into an annual total—once the per-unit 2024 list price is identified.
If you share your target indication, I can help compute the annual total
Skyrizi dosing can differ by indication, so annual cost calculations can vary. If you confirm the indication (psoriasis vs psoriatic arthritis vs Crohn’s disease, etc.) and the formulation, I’ll help you compute the 2024 annual list price using the per-unit list price from your chosen pricing source.
---
Sources used: none (the needed 2024 Skyrizi list-price number is not included in the provided information).